PPARD and intestinal neoplasm: GW501516 treatment significantly decreased CD8+ T -cell proliferation (Fig. 1A) and IFNγ-expressing CD8+ T cells (Fig. 1B) in intestinal tumors and matched normal tissues compared with the control group, suggesting PPARδ regulates CD8+ T-cell activation.